Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
Jenny-Avital
Elizabeth R
ER
D000225:Adenine / Q000031:analogs & derivatives / Q000627:therapeutic use; D015519:Bone Density / Q000187:drug effects; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D024882:Drug Resistance, Viral / Q000235:genetics*; D000068679:Emtricitabine; D006678:HIV / Q000235:genetics*; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D009154:Mutation; D063065:Organophosphonates / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D000068698:Tenofovir; D015215:Zidovudine / Q000627:therapeutic use
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D003841:Deoxycytidine; D019259:Lamivudine; D015215:Zidovudine; D000068698:Tenofovir; D000068679:Emtricitabine; D000225:Adenine